AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, citing a surplus of updated vaccines.
The firm said the decision was taken because of a decline in demand for the vaccine.
One of those seeking compensation is for injuries linked to AstraZeneca's vaccine is father-of-two and IT engineer Jamie ...
AstraZeneca withdraws Covid-19 vaccine globally due to surplus of updated vaccines. Admitted vaccine can cause blood clot ...
In wat een dramatische wending in de saga rond COVID-19 vaccins genoemd kan worden, heeft AstraZeneca aangekondigd haar COVID ...
Drugmaker AstraZeneca is reportedly pulling its COVID-19 vaccine from global markets due to a surplus of updated alternatives ...
"As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines," the ...
AstraZeneca will withdraw its coronavirus vaccines, British media reported Wednesday. The decision by the British-Swedish ...
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy. The jab, developed at Oxford University, was ...
AstraZeneca said it was "incredibly proud" of the vaccine, but it had made a commercial decision. It said the rise of new coronavirus variants meant demand had shifted to the newer updated vaccines.
, opens new tab said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic. The company also said it ...
The company faced a class-action lawsuit that claimed the vaccine caused TTS – which stands for Thrombosis with ...